United States Federal Circuit
In Re: Janssen Biotech, Inc., 17-1257
Affirming the rejection of claims for obviousness-type double patenting in the rejection of an attempt to extend the length of an expiring patent through re-application.
Appellate Information
- Published 2018/01/23
Judges
- PROST
Court
- United States Federal Circuit